ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regen Biopharma Inc (PK)

Regen Biopharma Inc (PK) (RGBP)

0.086
-0.014
(-14.00%)
Cerrado 17 Diciembre 3:00PM

Mejore su cartera: debates en tiempo real e ideas comerciales prácticas.

Estadísticas y detalles clave

Último Precio
0.086
Postura de Compra
0.07
Postura de Venta
0.36
Volume Operado de la Acción
34,399
0.085 Rango del Día 0.095
0.02 Rango de 52 semanas 1.50
Precio Anterior
0.10
Precio de Apertura
0.085
Última hora de negociación
Volumen promedio (3 m)
18,965
Volumen financiero
US$ 2,942
Precio Promedio Ponderado
0.085517

RGBP Últimas noticias

WPUR 29,000% 52-Week Gain Proves Water Can Be As Valuable As Gold

November 5, 2021 -- InvestorsHub NewsWire -- via Hawk Point Media --  MarketWatch Drilling for oil isn't the only way to get rich. Finding water can generate similar results...

WSGF - World Series of Golf Inc Stock In Play Ahead Of Planned "Transformational" Announcement In October

October 12, 2021 -- InvestorsHub NewsWire -- via Hawk Point Media --  Benzinga World Series of Golf, Inc. (OTC:WSGF) stock is in play ahead of what could be a transformative...

CEO Presenting on the Emerging Growth Conference on October 13 Register Now

Niche Companies in Technology, Biotech / Pharma, FinTech, Exploration, Wellness, and more in Attendance.   Miami, FL -- October 11, 2021 -- InvestorsHub NewsWire -- EmergingGrowth.com...

CEO Presenting on the Emerging Growth Conference on September 29  Register Now

CEO Presenting on the Emerging Growth Conference on September 29  Register Now Niche Companies in Technology, Biotech / Pharma, FinTech, Exploration, Wellness, and more in Attendance. Miami...

WNRS - Shares Up as Company Looks to Bring Sports Wagering to Pennsylvania

Sep 10, 2021 -- InvestorsHub NewsWire -- via BayStreet Pennsylvania is home to great sports teams—Steelers, Eagles, Phillies, Flyers—and is also one of the top sports...

Seeking Alpha - ALYI - Alternet Systems to reach $1M in sales with a gross margin beating competitors

September 3, 2021 -- InvestorsHub NewsWire -- via pennymillions --    Alternet Systems, Inc. (ALYI)By: Manshi Mamtora, CFA   Alternet...

CEO Presenting on the Emerging Growth Conference on September 1.  Register Now

CEO Presenting on the Emerging Growth Conference on September 1.  Register Now Niche Companies in Technology, Apparel, Apps, Technology, Ecommerce, and more in Attendance. Miami, Florida August...

CLNV - Breakthrough Technology Breaths Life Back Into Our Oceans - Zero-Emissions Process May Transform the $41.47 Billion Recycled Plastics Market

August 27, 2021 -- InvestorsHub NewsWire -- via The Market Highlights Clean Vision Corp. U.S. OTC: (CLNV) CLNV – Clean Vision’s Clean-Seas Files Patent for Its Global...

WNRS Signals VERY BULLISH - VegasWinners Inc Gears Up For Football Season With New Cryptocurrency And Website

August 20, 2021 -- InvestorsHub NewsWire -- via pennymillions --  BullishInvestor.com/WNRS Winners, Inc. is today reported to be singaling VERY BULLISH by Bullish Investor...

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10.008911.54345006490.07710.10790.0661247490.09275181CS
40.0067.50.080.12990.0551282950.08347397CS
12-0.174-66.92307692310.260.540.02189650.12649193CS
26-0.989-921.0751.10.02166070.28839319CS
52-0.514-85.66666666670.61.50.02170670.55042892CS
156-22.864-99.625272331222.9524.30.021149595410.82851207CS
260-0.214-71.33333333330.3122.850.00154473056826.55410235CS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
IBKKFImining Technologies Inc (CE)
US$ 0.05
(4,999,900.00%)
833
WRCDFWirecard AG (CE)
US$ 0.01
(999,900.00%)
250
SLAAFSitios Latinoamerica SAB de CV (PK)
US$ 0.189
(94,400.00%)
21.85k
MIKPMike The Pike Productions Inc (CE)
US$ 0.0002
(19,900.00%)
520k
KBNTKubient Inc (CE)
US$ 0.0002
(19,900.00%)
1.48k
AMHGQAmergent Hospitality Group Inc (CE)
US$ 0.000001
(-100.00%)
76.67k
CLVRClever Leaves Holdings Inc (CE)
US$ 0.000001
(-100.00%)
240
NEPTFNeptune Wellness Solutions Inc (CE)
US$ 0.000001
(-100.00%)
3.72k
ORMTQOrmet Corp (CE)
US$ 0.000001
(-99.99%)
500k
RKIGFReko International Group Inc (PK)
US$ 0.0006
(-99.98%)
100
RDARRaadr Inc (PK)
US$ 0.001
(-28.57%)
320.76M
HMBLHUMBL Inc (PK)
US$ 0.0012
(-4.00%)
311.02M
MMEXMMEX Resources Corporation (PK)
US$ 0.0001
(9,900.00%)
265.88M
EARIEntertainment Arts Research Inc (PK)
US$ 0.0001
(0.00%)
213.32M
CGACCode Green Apparel Corp (PK)
US$ 0.0005
(-16.67%)
125.52M

RGBP Discussion

Ver más
SidVicious SidVicious 4 días hace
The fat bastard CEO still hasn't shown he can do much to run a company. But, he is sure good at spending money on himself by boating and purchasing a Maserati. He can't even raise money to fund the P1 trial for HemaX now that he's done a complete 360 back to after abandoning it years ago and realizing he can't advance any of the other therapies. He and Loser Lander are are incompetent conmen. Heck, Koos is still showing "scientific" advisors that aren't advising him at all on his website to make it appear he has a competent team. That's just fraud.
👍 1
SmellMyFinger SmellMyFinger 4 días hace
We'll see. We'll see.
👍️0
Bigfootbud Bigfootbud 4 semanas hace
Regen BioPharma, Inc. Expands Vision for Phase 1 Clinical Trial of HemaXellerate

SAN DIEGO, Nov. 19, 2024 (GLOBE NEWSWIRE) -- Regen BioPharma, Inc. (OTC Pink: RGBP and RGBPP) today provided further insight into its planned Phase 1 clinical trial of HemaXellerate™, the company’s innovative stem cell-derived therapy, which has already received FDA clearance. While the initial focus is on treating aplastic anemia, Regen BioPharma is evaluating expanded applications for this groundbreaking therapy in a market poised for significant growth.

HemaXellerate™ is designed to stimulate bone marrow regeneration following injury caused by autoimmune conditions, chemotherapy, or radiation. While the company’s initial target is aplastic anemia—a rare orphan indication—it sees substantial potential in treating chemotherapy-induced bone marrow suppression, a market valued at over $1 billion annually. This is evidenced by the success of products like Neulasta, which addresses similar unmet needs.

“Aplastic anemia patients without access to bone marrow transplantation face limited options,” said Dr. David Koos, Chairman and CEO of Regen BioPharma. “With FDA clearance to begin clinical trials, HemaXellerate™ has the potential to redefine the treatment landscape—not just for aplastic anemia but for a wide range of hematological disorders. This is a pivotal moment for our company as we work to deliver life-changing therapies to patients worldwide.”

To ensure the trial’s success, Regen BioPharma has partnered with a clinical research organization (CRO) known for its expertise in conducting complex trials. Once initiated, the study is expected to reach completion within 12 to 14 months.

Key Highlights for Investors:

Opportunity: Aplastic anemia is a rare disease with high unmet medical need, offering the potential for accelerated regulatory pathways and market exclusivity.

Massive Market Potential: Expansion into chemotherapy-induced bone marrow suppression could unlock a multi-billion-dollar market.

Strategic Execution: Collaboration with a leading CRO ensures focused execution and timeline adherence.

About Regen BioPharma, Inc.

Regen BioPharma, Inc. is a publicly traded biotechnology company (PINK: RGBP) and (PINK: RGBPP). The Company is focused on the immunology and immunotherapy space. The Company is focused on rapidly advancing novel technologies through pre-clinical and Phase I/ II clinical trials. Currently, the Company is focused on mRNA and small molecule therapies for treating cancer and autoimmune disorders. Additional information on Regen BioPharma is available at http://www.regenbiopharmainc.com.

https://finance.yahoo.com/news/regen-biopharma-inc-expands-vision-210500940.html
👎️ 1 🤢 1
Here Today Here Today 4 semanas hace
https://www.otcmarkets.com/stock/RGBP/news/story?e&id=3052310
👎️ 1
Here Today Here Today 4 semanas hace














🤢 1
Fdc4 Fdc4 2 meses hace
If the cancer part is accurate, this is where I potentially speaking see this shell to be finally acquired. Hopefully he finally let us go
🤢 1
SmellMyFinger SmellMyFinger 2 meses hace
I couldn't agree with you more on this.
🤟 1 🥶 1
SidVicious SidVicious 3 meses hace
where are you hearing this? Remember, he resigned as CEO of REGEN with no reason given and no one to take over for about a year before he came back. It was at that time the pump of the decade happened with the stock. I wouldn't be surprised if he did have some sort of health issues. He hasn't looked healthy.
👍️0
QUEEN2 QUEEN2 3 meses hace
Rumor has it that Kooscous has serious cancer and has gone to Tel Aviv for treatment. Incredibly, he used the medical field of cancer to swindle shareholders and karmic law punished him with a backlash.....
Boomerang !!!
👍️0
Fdc4 Fdc4 4 meses hace
Good luck with FINRA looking into it
👍️0
Huggy Bear Huggy Bear 4 meses hace
That's FINRA's department.
👍️0
Market Makers Exist Market Makers Exist 4 meses hace
Except in extremely rare cases, R/S are a scam. The SEC needs to make the rules more strict. Why is a company like Regen BioPharma with unaudited financials allowed to RS? There's no reason for it except to screw over shareholders.
👍️ 1
SmellMyFinger SmellMyFinger 4 meses hace
I've never witnessed a reverse/split help matters for any stock long-term.
👍️0
SidVicious SidVicious 4 meses hace
I just caught up with Konman Koos very informative vids from the emerging turd conferences he shows his fat face at. It is absolutely hilarious that they are trying to find funding for a P1 trial for HemaX. Funny how he did a 180. He abandoned HemaX long ago to push his other crap and those programs didn't go anywhere, he and Loser Lander had to go back to HemaX. It will be interesting to see if he can find a sucker to give him money to fund a P1 trial for HemaX. I don't think he's going to be lucky in finding another mark. Anyone doing their DD into Koos would realize he's a scam artist. Talking about scam artists, where is 29IQ?
👍️0
Market Makers Exist Market Makers Exist 5 meses hace
Who would've thought a reverse split would turn into a complete failure in the OTC. Going back to pennies.
👍️0
Huggy Bear Huggy Bear 5 meses hace
It means you lost a bunch more money messing around with another SCAM.
👍️0
okwife okwife 5 meses hace
yes i see.!! thanks! makes sense. i have rgbp and twice as much rgbpp
RGBPP O/S 10M! https://www.otcmarkets.com/stock/RGBPP/security
RGBP O/S 4.5M https://www.otcmarkets.com/stock/RGBP/security
👍️0
Here Today Here Today 5 meses hace
You should still have RGBP and if you were on record of holding any shares in RGBP or RGBPP before the close of the record date, then you were allotted a dividend share count. So let’s say you had 100 shares of RGBP before the market close on the record date, you would have received 200 shares of RGBPP as a dividend.
👍️0
okwife okwife 5 meses hace
RGBP WENT AWAY IN MY ACCOUNT AND NOW I HAVE RGBPP .. anyone know what this means? i know it means preferred but did the company decide to do away with rgbp??
👍️0
oceans11 oceans11 5 meses hace
Yes I’m a newbie with only decades on IHub (Check the posting history sonny boy).
I love your wide- eyed wonderment that you seem to have discovered a “scam” on the OTC. I’m impressed.
You must have been equally amazed that the sun came up this morning, LOL
Tooooooo funny….
👍️0
Fdc4 Fdc4 5 meses hace
You sound like a newbie, you have not idea what you’re talking about. This company is 100% scam and it is manipulated in such way to lock in every investor that trades heavy. If you are talking about penny seekers that invest $50-$100 only, then. I believe you will find liquidity to get out but good luck with making profits with fees.
👍️0
oceans11 oceans11 5 meses hace
Actual traders bought at sub .30 a little back and are doing their flip thing while the pretenders resort to playground name-calling because that’s all they’ve got.
Wow- how easy the simple are satisfied.
I think I’d rather have the cash…

LMAO
👍️0
Huggy Bear Huggy Bear 5 meses hace
The scam is now 43 cents fool. Quit trying to con people, it's pathetic.
👍️0
oceans11 oceans11 5 meses hace
That post aged really, REALLY well.
So I guess your red letter prediction for tomorrow is another 60% gain?
Cooooool

LMAO
👍️0
QUEEN2 QUEEN2 5 meses hace
Hot summer ?
Yes ! but downwards.
Money back ?
Not with the conman liar thief Kouscous...
👍️ 1
robertus robertus 5 meses hace
What's the plan, Koos? Anyone? Hot summer in front of us?
The big question is how do we get our money back.
I think Rgbpp and Rgbp will come under same umbrella as one class of shares soon. After a share dividend shareholders should not be against such a decision.
Market capitalisation of Rgbp was only a million or so. If there is any meat in the Regen's science the price of the company should be attractive even to individuals if not companies.
👍️0
WV resident WV resident 5 meses hace
This is just about cooked.
👍️0
gotinearly gotinearly 5 meses hace
My divi showed up today
👍️0
29YEARINVESTOR 29YEARINVESTOR 5 meses hace
Rgbp Short Sale Volume (Off-Exchange Provided by FINRA) over 67% Friday
https://fintel.io/ss/us/rgbp
Scroll down to Short Sale Volume (Off-Exchange Provided by FINRA)
👍️0
Huggy Bear Huggy Bear 5 meses hace
Oh we know.

Keep scamming. It's what Koos Koos does for a sordid living.
👍️0
Fdc4 Fdc4 5 meses hace
Nobody knows what Koos is planning after this unexpected gift to shareholders!!! Hmm. Big tax break for REGEN Biopharma
👍️0
WV resident WV resident 5 meses hace
Cause still down over 95%
👍️0
all the way up green all the way up green 5 meses hace
My guess is that your broker is in the process of paying out your dividend. My account on the other hand shows nothing, no change at all.
👍️0
29YEARINVESTOR 29YEARINVESTOR 5 meses hace
Does anyone know why our rgbp shares now show a number 75886M300 instead of the symbol rgbp and value at Schwab.

75886M300
REGEN BIOPHARMA INC
$226.63 3 336
$0.67453
N/A
N/A
-$3.63
N/A
👍️0
Fdc4 Fdc4 5 meses hace
I wanted to add, “Speculations Only”… Playing The Devil’s advocate in here, could it be possible an adquisición or buyout into REGEN Biopharma is on the works and these shares structure must be consolidated for the simplicity of such transaction? Getting Rgbpp out of the way, by bringing them into the common side, makes sense a buyout could be in the works

Anyone care to answer or add into such possibility?
👍️0
Fdc4 Fdc4 5 meses hace
Does anyone know the reason of this Dividend? I mean, WOW, thank you Koos, WOW, this is awesome!!! I didn’t see this coming, HE IS DA MAN!!! Anyways, can someone explain what’s the catch behind all this greatness? Koos doesn’t give nothing for free or for the faint of heart. Something is not right. It feels like he didn’t have space for dilution and this is a legal way to dilute the rgbpp shares, now that they are common
👍️0
Fdc4 Fdc4 5 meses hace
In a nutshell, you meant to say: This is Acid, a lemon. Keep it simple
👍️0
all the way up green all the way up green 5 meses hace
Once my accounts are credited, I'll have 4136 RGBPP shares between both accounts.
👍️0
Bun_Macs Bun_Macs 5 meses hace
Must be E*trade I have 2 other brokers and I have received mine. All the best!
👍️ 1
29YEARINVESTOR 29YEARINVESTOR 5 meses hace
Yep mine showed up also I only bought 335 shares July 1st I had a bid in for 1,000 shares but only got 335 filled the others did not fill.
I had 1 share left in my account from long ago. Now I have 672 free preferred shares.
I try to tell folks the record date does not matter with a special dividend only the ex- date. Now who ever sold to me on July 1st will not get the dividend.
RGBPP
REGEN BIOPHARMA, I 0%PFD SUBJ TO XTRO REDEMPTION
$391.98 3 672
$0.58333
+$257.58
+$0.38331
+$391.98

07/01/2024 Buy
Trade Details RGBP
REGEN BIOPHARMA INC
335
$0.6666 $6.95 -$230.26
👍️0
all the way up green all the way up green 5 meses hace
Well, I haven't received mine yet and I've been holding since 2021, it could be because all of me shares are in 2 of my E*TRADE's accounts.
👍️0
Bun_Macs Bun_Macs 5 meses hace
OK- all you bashers can now finally STFU! I received my RGBPP dividends shares in my brokerage account! 🐂🎤⚖️👏😝
👍️0
all the way up green all the way up green 5 meses hace
This was copied from stocktwits.

$RGBP
RGBP
Regen Biopharma Inc


Good morning! I spoke with both my Fidelity and Schwab brokerage accounts again this morning to verify that they can now see that the preferred share dividend is pending with today being the pay date and Friday the 5th being the effective ex-dividend date according to FINRA, and they both acknowledged that they are seeing the dividend on their end now and that I qualify for the record date, and I should see the RGBPP shares delivered into my accounts by Friday. Have a great day everyone!
👍️0
29YEARINVESTOR 29YEARINVESTOR 6 meses hace
.75 was the high today. I sold all but 1 share when KOO KOO KOO,s did the Crazy R/S.
I bought a little today for the first time since the R/S just to see if I would get the dividend.
What a lot of people dont know is usually if you sell your stock before one business day after the ex- date with a special dividend you lose the dividend to the buyer.
Sometimes a company pays a dividend in the form of stock rather than cash. The stock dividend may be additional shares in the company or in a subsidiary being spun off. The procedures for stock dividends may be different from cash dividends. The ex-dividend date is set the first business day after the stock dividend is paid (and is also after the record date).

If you sell your stock before the ex-dividend date, you also are selling away your right to the stock dividend. Your sale includes an obligation to deliver any shares acquired as a result of the dividend to the buyer of your shares, since the seller will receive an I.O.U. or "due bill" from his or her broker for the additional shares. Thus, it is important to remember that the day you can sell your shares without being obligated to deliver the additional shares is not the first business day after the record date, but usually is the first business day after the stock dividend is paid.
https://www.investor.gov/introduction-investing/investing-basics/glossary/ex-dividend-dates-when-are-you-entitled-stock-and
👍️0
all the way up green all the way up green 6 meses hace
RGBPP is up 0.25 today @ $1.75
👍️0
all the way up green all the way up green 6 meses hace
So, does anyone believe there will be a 1RGBP for 2RGBPP dividend paid out this week? and if there is a dividend, will RGBPP go up or down? inquiring minds want to know. I read that this was to take place around July 01st.
TIA
👍️0
SmellMyFinger SmellMyFinger 6 meses hace
It's been a while since this last popped.
👍️0
all the way up green all the way up green 6 meses hace
Item 5.03 Amendments to Articles of Incorporation

On May 20, 2024 Regen Biopharma, Inc. amended its Certificate of Incorporation adding the following Article 8 which is and reads as follows:

Shares of one class or series of stock may be issued as a share dividend in respect of another class or series.

Item 8.01 Other Events.

On May 21 , 2024 the Board of Directors of Regen Biopharma, Inc.(“Regen”) declared a dividend to all shareholders of record as of June 20,2024 (“Record Date”) to be paid to shareholders on or about July 1, 2024 such dividend to be payable in shares of the Regen’s authorized but unissued Series A Preferred Stock and to consist of two share of Series A Preferred Stock for every one share of Regen Biopharma, Inc. Common Stock owned as of the Record Date, every one share of Regen Biopharma, Inc. Series A Preferred Stock owned as of the Record Date, every one share of Series AA Preferred Stock owned as of the Record Date, every one share of Series M Preferred Stock owned as of the Record Date and every one share of Series NC Preferred Stock owned as of the Record Date

Item 9.01 Financial Statements and Exhibits
👍️0
oceans11 oceans11 6 meses hace
Red posts are a sad cry to “please put me on the Iggy bus cause nobody reads red”
Soooooo long…..
👍️0
QUEEN2 QUEEN2 6 meses hace
SidVicious

Re: Ultraz2 post# 31672

Sunday, 12/03/2017 3:09:18 PM

The CEO David Koos has never shown any success at running anything. He's run all of his companies into the ground. It's pretty much a scam for him to earn a paycheck and his trips to Tijuana to do things that aren't legal in the USA.

Koos is a snake oil salesman.

I keep asking what successes Koos has had in making money for his stockholders or running a company or bringing a druge to market. No one will answer because they all know the answer. ZERO. He's a failure.

He keeps creating new companies after he's bleed dry the other companies.

Look at the so called business plan. He's not stuck to it one bit. It's a unworkable business plan. It's a failure just like Koos is.

Regen is like buying a lotto ticket. You think you have a chance but in reality, you are just throwing your money away.
👍️0